A substantial body of evidence demonstrated a decreased expression and activity of ALDH1A1 in PD patients’ nigrostriatal neurons, highly affecting dopamine catabolism and increasing DOPAL levels14. This evidence concerns the gene ALDH1A1 and Parkinson disease.